Summary
GlobalData's clinical trial report, “Systemic Idiopathic Juvenile Arthritis Global Clinical Trials Review, H2, 2018" provides an overview of Systemic Idiopathic Juvenile Arthritis clinical trials scenario. This report provides top line data relating to the clinical trials on Systemic Idiopathic Juvenile Arthritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
F. Hoffmann-La Roche Ltd
Novartis AG
Pfizer Inc
Regeneron Pharmaceuticals Inc
Bristol Laboratories Group Ltd
Italfarmaco Holding SpA
International Maternal Pediatric Adolescent AIDS Clinical Trials Network (USA)
Horizon Pharma Plc
Asklepios Kliniken GmbH
Amgen Inc
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Systemic Idiopathic Juvenile Arthritis to Musculoskeletal Disorders Clinical Trials 17
Clinical Trials by Phase in G7 Countries 19
Clinical Trials in G7 Countries by Trial Status 20
Clinical Trials by E7 Countries: Proportion of Systemic Idiopathic Juvenile Arthritis to Musculoskeletal Disorders Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 25
In Progress Trials by Phase 26
Clinical Trials by Trial Status 27
Clinical Trials by End Point Status 28
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials 33
Prominent Drugs 35
Clinical Trial Profile Snapshots 36
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 70
Contact Us 71
Disclaimer 71
Source 71
List of Tables
Systemic Idiopathic Juvenile Arthritis Therapeutics, Global, Clinical Trials by Region, 2018* 8
Systemic Idiopathic Juvenile Arthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 10
Systemic Idiopathic Juvenile Arthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 11
Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 12
Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 13
Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials, North America, Top Countries, 2018* 14
Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 15
Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 16
Proportion of Systemic Idiopathic Juvenile Arthritis to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2018* 18
Systemic Idiopathic Juvenile Arthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 19
Systemic Idiopathic Juvenile Arthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20
Proportion of Systemic Idiopathic Juvenile Arthritis to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2018* 22
Systemic Idiopathic Juvenile Arthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Systemic Idiopathic Juvenile Arthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Systemic Idiopathic Juvenile Arthritis Therapeutics, Global, Clinical Trials by Phase, 2018* 25
Systemic Idiopathic Juvenile Arthritis Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 26
Systemic Idiopathic Juvenile Arthritis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 28
Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 29
Systemic Idiopathic Juvenile Arthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 30
Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32
Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34
Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 35
List of Figures
Systemic Idiopathic Juvenile Arthritis Therapeutics, Global, Clinical Trials by Region (%), 2018* 8
Systemic Idiopathic Juvenile Arthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Systemic Idiopathic Juvenile Arthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 11
Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 12
Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 13
Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 14
Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 15
Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 16
Proportion of Systemic Idiopathic Juvenile Arthritis to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2018* 17
Systemic Idiopathic Juvenile Arthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 19
Systemic Idiopathic Juvenile Arthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20
Proportion of Systemic Idiopathic Juvenile Arthritis to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2018* 21
Systemic Idiopathic Juvenile Arthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Systemic Idiopathic Juvenile Arthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Systemic Idiopathic Juvenile Arthritis Therapeutics, Global, Clinical Trials by Phase (%), 2018* 25
Systemic Idiopathic Juvenile Arthritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 26
Systemic Idiopathic Juvenile Arthritis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 28
Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 29
Systemic Idiopathic Juvenile Arthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 30
Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 31
Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 33
Systemic Idiopathic Juvenile Arthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 35
GlobalData Methodology 70
